Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FZ833
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,838
Award facts
- Contract value 100% obligated
- $14,837.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,837.67 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on January 6, 2026, with an ultimate completion date of January 7, 2026, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors to supply the Department of Defense with comprehensive pharmaceutical and medical consumables support.
DMS Pharmaceutical Group supplies an extensive portfolio of pharmaceutical products to federal agencies, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables across multiple therapeutic categories. As a critical supplier within the federal pharmaceutical supply chain since its registration in the System for Award Management in July 2001, the company has demonstrated substantial federal contracting activity and consistent performance across numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division. The underlying PPV-G GEN V contract, awarded on November 13, 2025, carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, positioning DMS Pharmaceutical Group to serve as a key pharmaceutical supplier for Department of Defense healthcare operations globally through a 30-month base period with three optional 30-month extension periods.
Quick answers
Who was awarded contract SPE2DU26FZ833?
SPE2DU26FZ833 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DU26FZ833 worth?
The government has obligated $14,838 on SPE2DU26FZ833.
Is contract SPE2DU26FZ833 an order under another contract?
Yes. SPE2DU26FZ833 is a delivery order under SPE2DU25D9434, an indefinite delivery contract.
Was contract SPE2DU26FZ833 competed?
The extent of competition for SPE2DU26FZ833 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award